Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05858060 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Osmotic Therapy for Patients With Severe Subarachnoid Hemorrhage

Study acronym: OSMO-SAH
StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed Show 4 more changesShow less
    • Study completion date changed from estimate of Dec 31, 2025 to Jan 31, 2026
    • Eligibility criteria shortened, about 6 words
    • Site details revised
    • Publications: details revised at 1 of 1 entry
  2. Site contact updatedv7
  3. Re-verified, no change to tracked fieldsv6
  4. Primary and study completion dates: Mar 31, 2024 to Dec 31, 2025
    • Eligibility criteria expanded, about 13 words
    • Site contact updated
    v5
  5. 2 versions Re-verified since Aug 4, 2023, no change to tracked fieldsv3-v4
  6. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Jun 1, 2023 to Jul 10, 2023
    • Site details revised
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this prospective multi-center observational study is to learn about the osmotic therapy in severe subarachnoid hemorrhage (SAH). The main question\[s\] it aims to answer are: • whether the two osmotic therapy, 20% mannitol and 10% hypertonic saline(HTS), under the same osmotic equivalent, has similar influence on the outcome of SAH patients? Participants will be given proper treatment according to local expert consensus, including the choice of osmotic medicine. Investigators just record and analyse the data, compare mannitol group and HTS group to see if the outcome of latter is not worse than the former.
Trial Details
NCT Number NCT05858060
Lead Sponsor Xuanwu Hospital, Beijing
Conditions
(from sponsor)		 Subarachnoid Hemorrhage, Traumatic
Related terms Subarachnoid Hemorrhage, Subarachnoid Hemorrhage, Traumatic
Enrollment 124 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov